Lotrimin Daily Prevention Deo Spray Recalled for Benzene Contamination Risk
Bayer Healthcare Pharmaceuticals is recalling Lotrimin Daily Prevention Deo (Tolnaftate) spray due to potential benzene contamination from manufacturing facility cGMP deviations. The product was distributed nationwide and internationally.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving potential chemical contamination (benzene) from facility deviations. While no reported illnesses or injuries are stated in the source, the hazard involves a known toxic substance at a facility with confirmed contamination history, placing this at the High level per the rubric.
Plain-English summary
Bayer Healthcare Pharmaceuticals Inc. is recalling Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray in 160g (5.6 oz) cans. The recall affects 579,456 units distributed nationwide in the US, Puerto Rico, Canada, and Mexico through various retail channels.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. The product was manufactured at a facility where other lots were found to be contaminated with benzene, a chemical known to pose health risks.
Affected lots include single-pack and 3-pack configurations with various lot numbers and expiration dates ranging from January 2022 through August 2022. Consumers should stop using the product and contact Bayer Healthcare for instructions on how to return it or dispose of it safely.
The recalled product
- Product
- LOTRIMIN DAILY PREVENTION DEO (TOLNAFTATE)
- Brand
- LOTRIMIN DAILY PREVENTION DEO
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Category
- Drug — Topical OTC Antifungal
- Affected units
- 579,456
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # (a)TN0023C
- EXP 1/31/2022
- TN003C7
- EXP 4/30/2022
- TN00570
- EXP 7/31/2022
- TN0056Z
- TN005KJ
- EXP 8/31/2022
- (b)TN0023C
- EXP 01/31/2022
- EXP 04/30/2022
- TN0023DV
- TN0023DAV
- TN0023DBV
- TN0023DC
- EXP 02/28/2022
- TN005KJA
- TN005KJB
- EXP 08/31/2022
UPCs (2)
- 041100587206
- 041100589613
Distribution
Part of a larger recall action
This product is one of 19 recalled by Bayer Healthcare Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same brand · LOTRIMIN DAILY PREVENTION DEO
- SevereLotrimin Daily Prevention Deo Tolnaftate Spray Recalled for Benzene Contamination
FDA (Drugs) · 2021-11-24
- HighLotrimin Daily Prevention Deo recalled for potential benzene contamination
FDA (Drugs) · 2021-11-24
- ModerateLotrimin Daily Prevention Deo Tolnaftate Spray Recalled for Potential Benzene Contamination
FDA (Drugs) · 2021-11-24
Same manufacturer · Bayer Healthcare Pharmaceuticals Inc.
See all →- SeverePrescription drug oral solution recalled for microbial contamination
FDA (Drugs) · 2023-12-06
- HighLotrimin AF Liquid Spray Recalled for Potential Benzene Contamination
FDA (Drugs) · 2021-11-24
- SevereLotrimin AF Powder Spray Recalled for Benzene Contamination
FDA (Drugs) · 2021-11-24
- SevereLOTRIMIN AF Powder Spray Recalled for Benzene Contamination Risk
FDA (Drugs) · 2021-11-24
- SevereLotrimin AF Deodorant Powder Spray Recalled for Benzene Contamination
FDA (Drugs) · 2021-11-24
Same hazard · benzene contamination
See all →- SevereSkin MD Body Acne Cleanser recalled due to elevated benzene levels
FDA (Drugs) · 2025-10-01
- ModerateLa Roche-Posay Effaclar Duo Acne Treatment Recalled for Benzene Contamination
FDA (Drugs) · 2025-05-21
- HighWalgreens Acne Cream Recalled for Benzene Contamination
FDA (Drugs) · 2025-03-26
- HighSecret Dry Spray Antiperspirant recalled due to potential benzene contamination
FDA (Drugs) · 2024-01-24
- HighSecret anti-perspirant spray recalled for potential benzene contamination
FDA (Drugs) · 2024-01-24